Endocrine Therapy Development Professors and Supervisors | ApplySharif

جست‌وجوی استاد و پژوهشگر

استاد راهنما، استاد دانشگاه یا پژوهشگر مناسب برای مسیر پژوهشی‌تان را پیدا کنید و با او ارتباط بگیرید.

نمایش ۳۱-۴۵ از ۱٬۷۶۴ استاد راهنما

اطلاعات این پروفایل‌ها از صفحات عمومی دانشگاه‌ها جمع‌آوری شده و ممکن است به‌روز نباشد.

Vicente Valeroمشاهده پروفایل

استاد

The University of Texas MD Anderson Cancer CenterUnited States

Dr. Vicente Valero is a Professor and Deputy Chairman in the Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center. He has been affiliated with MD Anderson since 1991, with expertise in breast cancer, particularly inflammatory breast cancer (IBC) and HER2-positive cancers. His academic credentials include an M.D. from Universidad Autonoma de Nuevo Leon, followed by postgraduate training in Internal Medicine at St. Elizabeth Hospital and Northeastern Ohio University College of Medicine, and fellowships in Hematology-Medical Oncology at the University of Cincinnati and The University of Texas Medical Branch in Galveston. Board-certified in Internal Medicine, Medical Oncology, and Hematology, Dr. Valero is a leading researcher in neoadjuvant therapies, molecular residual disease, and IBC treatment protocols. His research focuses on improving outcomes for metastatic breast cancer patients, optimizing surgical de-escalation strategies, and advancing immunotherapy and targeted therapies. He leads multiple clinical trials, including NRG-BR004 and NRG-BR003, and has authored over 150 peer-reviewed articles. Dr. Valero is recognized for his dedication to education, having received the Division of Medicine Teacher of the Year award twice and the Educator of the Month honor. He actively contributes to multidisciplinary quality assurance conferences and serves as a primary investigator for several funded research protocols. Key achievements include developing the R-IBC residual tumor burden calculator and pioneering studies on eliminating breast surgery for exceptional responders to systemic therapy. His work emphasizes translating research into clinical practice to enhance early detection, prevention, and treatment efficacy in breast cancer.

پروفایل رسمی دانشگاه

Deborah Goberdhanمشاهده پروفایل

دانشیار

University of OxfordUnited Kingdom

Dr. Deborah Goberdhan is an Associate Professor at the University of Oxford , affiliated with the Department of Physiology, Anatomy and Genetics (DPAG) . She leads an independent research group investigating amino acid sensing , mTORC1 signaling , and exosome-mediated communication in cancer progression using both human cancer cells and Drosophila models . She serves on the Cancer Research UK Oxford Centre Research Committee , teaches Medical and Biomedical Sciences undergraduates , and acts as Academic Public Engagement Lead for her department. Her research focuses on cell growth regulation through Proton-assisted Amino acid Transporters (PATs) , which function as 'transceptors' modulating mTORC1 activity . This work has expanded to examine exosome heterogeneity and therapeutic delivery mechanisms with support from BBSRC and Cancer Research UK . She co-founded Oxosome , the Oxford extracellular vesicle interest group , to foster interdisciplinary collaboration. Key research areas include Cancer cell communication via exosomes Amino acid signaling in tumor progression Drosophila as cancer model system Clinical collaborations with Prof Adrian L Harris , Prof Freddie C Hamdy , and Prof Clare Verrill Recent publications highlight her group's contributions to exosome biogenesis (2023), brain-targeted siRNA delivery (2021), and nutrient stress responses in cancer (2020). She actively promotes scientific communication through ISEV social media initiatives.

پروفایل رسمی دانشگاه

Michael DiGiovannaمشاهده پروفایل

استاد

Yale UniversityUnited States

Michael DiGiovanna is a Professor of Internal Medicine and Pharmacology at Yale School of Medicine, specializing in Medical Oncology with a focus on breast cancer. He holds clinical leadership roles including Chair of the Breast Cancer Tumor Board and educational leadership as Co-Director of the Pre-Clerkship Curriculum and Thread Leader in Pharmacology. MD and PhD from Yale University (1990) Residency and Fellowship at Yale School of Medicine Board Certified in Medical Oncology (ABIM) His research investigates signal transduction mechanisms in breast cancer, particularly HER2/EGFR/ER/IGF-I receptor interactions and their implications for targeted therapies. Clinical work spans pharmacology, oncology, and translational research with frequent co-authorship alongside Lajos Pusztai and Donald Lannin. Scientific Awards: American Cancer Society Research Scholar Grant Women's Health Investigator Award Swebilius Translational Cancer Research Award Alvan R. Feinstein Award Contact: Email: michael.digiovanna@yale.edu Office: 203.785.2876 Clinical: 203.200.2328

پروفایل رسمی دانشگاه

Kareen L K Coulombeمشاهده پروفایل

دانشیار

Brown UniversityUnited States

Kareen L.K. Coulombe is an Associate Professor of Engineering at Brown University, affiliated with the Institute for Biology, Engineering and Medicine . She collaborates with researchers from the Department of Medicine and institutions like the University of Edinburgh and ScitoVation, Inc . Education: B.S. in Biomedical Engineering, Summa Cum Laude (University of Rochester, 2001) Ph.D. in Bioengineering (University of Washington, 2007) Her research focuses on cardiovascular regenerative engineering , including: Developing human iPSC-derived cardiac tissues for heart attack therapy Creating anisotropic biomaterial scaffolds to enhance tissue integration Designing in vitro cardiotoxicity testing platforms for pharmaceuticals and environmental chemicals Optimizing electrical coupling between engineered and native heart tissue Recent publications highlight advancements in: Predictive 3D cardiac microtissue models for arrhythmic risk assessment Custom polycaprolactone scaffolds for tailored mechanical properties Immunomodulatory biomaterials that reshape cardiac repair processes Computational strain continuum modeling of cardiac tissue mechanics Scientific Awards: 2023 - Brown University Innovation of the Year 2021 - NSF CAREER Award & Young Innovator Award (BMES) 2019 - Dean’s Award for Excellence in Mentoring 2017-2012 - Rising Star Award & NIH Pathway to Independence K99/R00 Dr. Coulombe mentors students through programs like: Brown Leadership Alliance (undergraduate research) Tougaloo College Partnership (student development) NIH-IMSD Programs (graduate mentoring)

پروفایل رسمی دانشگاه

Andrew Godwinمشاهده پروفایل

استاد

University of KansasUnited States

Andrew Godwin is a Professor at the University of Kansas Medical Center , where he serves as the Chancellor’s Distinguished Chair in Biomedical Sciences and Director of Molecular Oncology in the Department of Pathology and Laboratory Medicine. He is also the Deputy Director of the NCI-designated University of Kansas Cancer Center and the Founding Director of the Kansas Institute for Precision Medicine and Biospecimen Shared Resource . Dr. Godwin is a leader in translational research and precision medicine , with a focus on molecular oncology , biomarker discovery , and genomic diagnostics . His work bridges basic and clinical science to improve cancer patient care, particularly in ovarian cancer , Ewing sarcoma , and breast cancer . He has contributed over 230 ovarian cancer-related publications and pioneered studies linking the PI3K/AKT pathway to cancer treatment targets. His research program encompasses liquid biopsies using extracellular vesicles , molecular therapeutics , companion diagnostics , and clinical trial validation . He leads the Biomarker Discovery Laboratory and has secured over $250M in extramural funding , including a $11.4M NIH grant for precision medicine initiatives. His team has developed CELLSEARCH® , the first FDA-cleared test for circulating tumor cells. Notable awards include the Dolph C. Simons, Sr. Higuchi Award (2020), Outstanding Mentorship in Pathology Award (2024), and multiple mentoring accolades from KU. He has mentored over 150 trainees across career stages and leads a multidisciplinary lab with expertise in genomics , proteomics , and bioengineering . Academic Roles: Chancellor’s Distinguished Chair in Biomedical Sciences Director, Molecular Oncology, Pathology and Laboratory Medicine Deputy Director, KU Cancer Center Founding Director, Kansas Institute for Precision Medicine Adjunct Professor, Bioengineering Program, University of Kansas Scientific Awards: KUMC Achievement Award for mentoring postdocs (2014) Chancellor’s Club Award for Research (2018) Dolph C. Simons, Sr. Higuchi Award (2020) KU Excellence in Mentoring Award (2021) Outstanding Mentorship in Pathology (2024) Key Research Themes: Extracellular vesicles as liquid biopsy tools Molecular mechanisms of sarcoma and breast cancer Genomic diagnostics and precision oncology Clinical trial biomarker validation Biospecimen repository leadership

پروفایل رسمی دانشگاه

Dirk Repsilberمشاهده پروفایل

استاد

Örebro UniversitySweden

Dirk Repsilber is a Professor of Medical Science at Örebro University, specializing in functional bioinformatics. He leads research on molecular patterns in patients to improve diagnosis and treatment. Born in Lübeck, Germany, he earned his PhD in ecological genetics from the University of Hamburg and held postdoctoral roles at institutions across Sweden and Germany. His work integrates bioinformatics, biostatistics, and clinical collaboration to address complex biological systems. Education: PhD in Ecological Genetics (University of Hamburg, 1999), postdoctoral training at Uppsala University and SLU, followed by roles at German institutions including Lübeck, Potsdam, Rostock, and Örebro. Research Interests: Molecular networks, biosignature development, systems biology approaches to genotype-phenotype mapping, and interdisciplinary collaborations in medicine, statistics, and computer science. Key Projects: BIO IBD (biomarker discovery in inflammatory bowel disease), Cell Painting for toxicity assessment, and systems-level immunomonitoring in pediatric oncology. Active in cross-disciplinary teams like the Center for Life Sciences Nutrition-Gut-Brain Interactions. Teaching & Supervision: Cross-disciplinary courses in bioinformatics, statistical counseling, and supervision of PhD students in diverse fields. Emphasizes problem-based learning and communication skills across disciplines.

پروفایل رسمی دانشگاه

Peter Schultzمشاهده پروفایل

استاد

Irell and Manella Graduate School of Biological SciencesUnited States

Peter Schultz, PhD, is the President and CEO of Scripps Research, holding the L.S. “Sam” Skaggs Presidential Chair in the Department of Chemistry. He has been a faculty member since 1999, previously at UC Berkeley. His research spans synthetic biology, genetic code expansion, and drug discovery, with a focus on engineering organisms and molecules for biological and medical applications. Education: Ph.D. in Chemistry, California Institute of Technology (1984) B.S. in Chemistry, California Institute of Technology (1979) Research Interests: Expanding genetic codes to incorporate noncanonical amino acids in organisms Engineering endosymbiotic systems to study mitochondrial evolution Developing small molecules for cancer, stem cell therapies, and neglected diseases Designing antibodies and CAR-T cells for targeted therapies Article Trends: Recent work emphasizes small molecule therapies for cancer and fibrosis, synthetic biology applications in endosymbiosis, and genetic code expansion for protein engineering. Key themes include drug repurposing, targeted drug delivery, and molecular mechanisms of biological systems. Awards: Wolf Prize in Chemistry (1994) National Academy of Sciences Member (1993) Paul Ehrlich-and Ludwig Darmstaedter Prize (2002) National Academy of Inventors Fellow (2015) Advising & Grants: Supervises ~15 graduate students and postdocs annually. Secured funding from NSF, NIH, and industry partnerships. Over 85 former students hold academic positions globally. Labs/Teams: Heads the Schultz Lab at the Chi-Huey Wong Laboratories, focusing on biologically inspired synthesis and translational research.

پروفایل رسمی دانشگاه

Rodney Baberمشاهده پروفایل

استاد بالینی

University of SydneyAustralia

Clinical Professor Rodney Baber is affiliated with the University of Sydney through its Northern Clinical School in the Department of Obstetrics, Gynaecology and Neonatology . His research focuses on Reproductive medicine , Menopause , and Premature Ovarian Failure , with particular emphasis on hormone therapy applications and postmenopausal health risks. Obstetrics and Gynaecology Menopausal Medicine Reproductive Endocrinology Non-hormonal Therapies Recent publications demonstrate strong engagement with menopausal hormone therapy controversies, cardiovascular risk assessment , non-hormonal treatment alternatives , and postmenopausal complication management . Collaborative work with international experts appears across multiple high-impact journals.

پروفایل رسمی دانشگاه

Paul Fletcherمشاهده پروفایل

استاد

University of CambridgeUnited Kingdom

Professor Paul Fletcher is a Principal Investigator at the Institute of Metabolic Science, University of Cambridge, and holds the Bernard Wolfe Health Neuroscience Fund. He is affiliated with the Department of Psychiatry and collaborates with Professors Steve O’Rahilly, Sadaf Farooqi, Fiona Gribble, and Frank Reimann. His research bridges neuroscience and psychiatry to explore higher-level perceptual and learning processes shaping decision-making and behavior, particularly in relation to obesity and mental disorders. Academic Rank: Professor University: University of Cambridge School: Institute of Metabolic Science Department: Psychiatry Fletcher employs functional neuroimaging, behavioral studies, and pharmacological perturbations (e.g., dopamine agonists/antagonists) to investigate reward-related brain processes and their role in food choice, obesity, and psychiatric conditions like psychosis. His work emphasizes the integration of the brain with metabolic/endocrine signals and external environments. Key trends in his publications include predictive coding , delusions , neuroimaging , and virtual reality applications in mental health. Recent studies focus on anxiety , foraging behavior , schizophrenia , and health interventions . Scientific Awards Bernard Wolfe Health Neuroscience Fund Wellcome Trust Senior Clinical Fellow Fletcher’s research is funded by Wellcome and the Bernard Wolfe Fund, with collaborations spanning psychiatry, psychology, and clinical neuroscience. His work addresses mental health , obesity , and neurocognitive mechanisms of decision-making, supported by recent publications in top-tier journals.

پروفایل رسمی دانشگاه

Alvaro Köhn-Luqueمشاهده پروفایل

دانشیار

University of OsloNorway

Alvaro Köhn-Luque is an Associate Professor at the Oslo Center for Biostatistics and Epidemiology, University of Oslo, and Group Leader at the Department of Medical Genetics, Oslo University Hospital. His work bridges mathematical modeling with clinical applications, particularly in cancer research. His academic background includes a PhD in Mathematical and Computational Biology from Complutense University of Madrid (2012), preceded by multiple Master's degrees in Mathematics and Physics from Spanish universities. Dr. Köhn-Luque's research focuses on mathematical oncology , developing computational models to understand cancer dynamics and improve treatment strategies. His work spans multiscale modeling of tumor growth, personalized cancer medicine through computer simulations, and biomarker discovery using machine learning approaches. He has made significant contributions to modeling breast cancer progression and treatment response, particularly in the context of endocrine therapy and CDK4/6 inhibition. His recent publications demonstrate a strong trend toward integrating mechanistic learning approaches that combine mathematical models with machine learning techniques. This hybrid methodology allows for more accurate prediction of treatment outcomes while maintaining biological interpretability. His work frequently involves collaboration with clinical researchers to ensure models are grounded in real patient data and have direct translational potential. Computational modeling of tumor heterogeneity and drug response Development of methods for phenotypic deconvolution in cancer cell populations Integration of multi-omics data for personalized treatment prediction Application of birth-death processes to model tumor evolution Creation of user-friendly computational tools for biomedical researchers Dr. Köhn-Luque has supervised multiple PhD students including Even M Myklebust, Salim Ghannoum, and Xiaoran Lai, and has secured funding for projects including RESCUE, BigInsight, and Integreat. His research demonstrates a consistent trajectory from theoretical mathematical biology toward increasingly clinically relevant applications in personalized cancer medicine.

پروفایل رسمی دانشگاه

Xiang Zhangمشاهده پروفایل

استاد

Baylor College of MedicineUnited States

Xiang Zhang is a Professor in the Department of Molecular and Cellular Biology at Baylor College of Medicine (BCM), serving as Director of the Lester and Sue Smith Breast Center and holder of the William T. Butler, M.D., Endowed Chair. He also holds roles as a McNair Scholar and member of the Dan L. Duncan Comprehensive Cancer Center. Zhang’s research focuses on metastasis mechanisms and immunology, particularly in breast cancer bone metastasis. His work bridges tumor cell behavior with the tumor microenvironment, emphasizing spatiotemporal co-evolution and therapeutic development. Education: Ph.D. from Columbia University (2006), Postdoctoral Fellowship at Memorial Sloan Kettering Cancer Center (2011), and B.S. from Fudan University (2000). Honors include the Era of Hope Scholar Award (2016-2021) and NIH Pathway to Independence Award (2010-2014). Research Themes: 1) Breast cancer bone metastasis mechanisms, including niche interactions and osteogenic signaling. 2) Tumor immunology, focusing on immune suppression, myeloid cell dynamics, and therapy resistance. Recent breakthroughs include lipid-driven immune evasion in triple-negative breast cancer and single-cell profiling of metastatic ecosystems. Publications highlight discoveries in bone microenvironmental reprogramming, myeloid-B cell crosstalk, and therapeutic vulnerabilities. His lab actively explores biomarkers for therapy response and novel combination therapies. Grants and Awards: Over $15M in NIH/NCI grants, Department of Defense funding, and foundation support. Notable recognition includes the Michael E. DeBakey Award (2018) and Laura Zisken Prize (2020). Lab Team: Includes postdoctoral researchers (Noa Peled, Xuan Li) and students (Michael Dieffenbach). Current projects investigate lipid metabolism in therapy resistance and systemic immunosuppression mechanisms. Laboratory: Established in 2011, the Zhang Lab employs preclinical models, single-cell analysis, and translational approaches to combat metastasis. Active collaborations include work with the BCM Immunity Center and Stand Up To Cancer initiatives.

پروفایل رسمی دانشگاه

Thomas Kaminskiمشاهده پروفایل

استاد

University of DelawareUnited States

Thomas W. Kaminski is a Professor in the Department of Kinesiology & Applied Physiology at the University of Delaware’s College of Health Sciences. His research focuses on sensorimotor and neurocognitive aspects of musculoskeletal injuries, particularly chronic ankle instability, sport-related concussions, and repetitive head impacts in soccer. He directs the Athletic Training Research Laboratory, established in 2003, which collaborates with departments across UD, including Athletics, Physical Therapy, and Engineering. Education: PhD in Sports Medicine (University of Virginia, 1996), MS in Athletic Training (University of Arizona, 1985), BS in Sports Medicine (Marietta College, 1984). Courses taught include Evidence-Based Sports Medicine, Upper/Lower Extremity Evaluation, and Clinical Practicum. Research emphasizes injury prevention, biomechanical analysis, and rehabilitation strategies. His lab uses advanced tools like the KinCom Isokinetic Dynamometer, Bortec EMG systems, and Triax Impact Monitors. Current projects include studying neck strengthening programs for youth soccer players and blood biomarkers in concussion recovery. Grants and collaborations involve the NCAA-DoD CARE Consortium, focusing on collegiate athletes and military cadets. Lab initiatives aim to translate findings into broader health applications for physically active populations. Lab facilities include the Human Performance Lab and partnerships with UD Physicians, Student Health Services, and regional sports programs. Active research areas include concussion symptom evolution, sex-based injury differences, and the effects of sport specialization on cognitive/postural functions.

پروفایل رسمی دانشگاه

Anton Pottegårdمشاهده پروفایل

استاد

University of Southern DenmarkDenmark

Anton Pottegård is a Professor at the University of Southern Denmark and Head of Research at Hospital Pharmacy Funen (Odense University Hospital). His work combines registry-based pharmacoepidemiological research with clinical investigations into deprescribing practices. Affiliation: University of Southern Denmark Secondary Role: Head of Research, Odense University Hospital Research interests focus on pharmacoepidemiology and clinical pharmacy , particularly real-world drug safety and deprescribing in geriatric care. His methodology emphasizes Danish healthcare registries for longitudinal analyses of medication patterns and adverse outcomes. Notable contributions include epidemiological analyses of opioid utilization , migraine treatments , and GLP-1 receptor agonists . He has developed frameworks for pharmacoepidemiological methodology and drug safety surveillance , co-authored over 300 publications, and led the REDO project on reducing opioid use in osteoarthritis. Additional activities include media commentary on TBE vaccination and tick-borne diseases , with 613 press/media appearances reflecting public health engagement. Supervised work includes 7 doctoral candidates and cross-national collaborations.

پروفایل رسمی دانشگاه

Arnoldo Frigessiمشاهده پروفایل

استاد

University of OsloNorway

Arnoldo Frigessi is Professor of Statistics at the University of Oslo, where he leads the Oslo Center for Biostatistics and Epidemiology and serves as director of BigInsight—a Centre of Excellence for Research-Based Innovation. This consortium unites industry, business, public actors, and academia to develop model-based machine learning methodologies for big data, with strong emphasis on health applications. His research centers on statistical methodology driven by real-world scientific challenges, specializing in stochastic models for complex dependence structures and computationally intensive inference algorithms. Core application domains include: Genomics and personalized cancer therapy (particularly breast and lung cancer) Infectious disease modeling (including pandemic response) eHealth, sensor data analysis, and recommender systems Personalized marketing and viral diffusion dynamics Analysis of his 15 most recent publications (2024-2025) reveals dominant themes in cancer systems biology , where he integrates multi-omics, single-cell transcriptomics, and computational modeling to decode tumor evolution under therapy. Parallel work advances infectious disease epidemiology through time-varying reproduction number estimation and mobility-based transmission modeling, while methodological innovations span synthetic data generation (TVineSynth), causal inference via target trial emulation, and Bayesian ranking models for recommender systems. Scientific Awards: No specific awards mentioned in source materials Frigessi actively supervises graduate students, including a Department of Informatics project on "Utilizing covariate information in recommender systems." His leadership of BigInsight—funded as a Research-Based Innovation Centre by the Research Council of Norway—secures major grants supporting interdisciplinary collaborations with industrial partners (e.g., Telenor, DNB) and public health institutions. Current projects integrate real-world clinical data with mechanistic models for treatment optimization. He directs BigInsight's multidisciplinary team of statisticians, computer scientists, and domain experts, while leading the Oslo Center for Biostatistics and Epidemiology's efforts in developing statistical frameworks for complex health data. These initiatives drive Norway's national strategy for data-driven health innovation.

پروفایل رسمی دانشگاه

Daniel Haleمشاهده پروفایل

استاد

Pennsylvania State UniversityUnited States

Daniel Hale is a Professor in the Department of Pediatrics and Chief of the Division of Endocrinology. His work focuses on pediatric endocrine abnormalities, particularly in children with genetic syndromes, growth disorders, and pubertal disorders. He is also active in medical student, resident, and provider education. Education: MD, University of Texas McGovern Medical School (1977) Pediatrics Residency, Medical University of South Carolina (1980) Pediatric Endocrinology Fellowship, Children's Hospital of Philadelphia (1983) Research Trends: Type 2 Diabetes in Youth Genetic Syndromes and Endocrinology Impact of CNS Stimulants on Pediatric Growth Glycemic Control and Complications in Diabetes Chromosome 18 Syndromes Collaborations: Extensive cross-institutional collaborations in diabetes, genetics, and child development. Grants: National Children's Study, GH Trial for Chromosome 18q- Syndromes, DM2 Risk in Mexican Youth, Telehealth Network Grants.

پروفایل رسمی دانشگاه

فقط ۷۵۰ نتیجه اول نمایش داده می‌شود. برای رسیدن به نتایج دقیق‌تر، جست‌وجو را با فیلترها محدودتر کنید.